Neogen/$NEOG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Neogen
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Ticker
$NEOG
Sector
Primary listing
Employees
2,974
Headquarters
Website
Neogen Metrics
BasicAdvanced
$1.4B
-
-$4.81
1.90
-
Price and volume
Market cap
$1.4B
Beta
1.9
52-week high
$15.13
52-week low
$3.87
Average daily volume
4.2M
Financial strength
Current ratio
3.584
Quick ratio
1.897
Long term debt to equity
37.475
Total debt to equity
37.511
Interest coverage (TTM)
-0.26%
Profitability
EBITDA (TTM)
100.769
Gross margin (TTM)
46.39%
Net profit margin (TTM)
-117.61%
Operating margin (TTM)
-2.03%
Effective tax rate (TTM)
2.85%
Revenue per employee (TTM)
$300,000
Management effectiveness
Return on assets (TTM)
-0.28%
Return on equity (TTM)
-39.71%
Valuation
Price to revenue (TTM)
1.564
Price to book
0.66
Price to tangible book (TTM)
-4.13
Price to free cash flow (TTM)
-439.84
Free cash flow yield (TTM)
-0.23%
Free cash flow per share (TTM)
-0.015
Growth
Revenue change (TTM)
-2.78%
Earnings per share change (TTM)
4,268.36%
3-year revenue growth (CAGR)
18.63%
10-year revenue growth (CAGR)
11.81%
3-year earnings per share growth (CAGR)
142.24%
10-year earnings per share growth (CAGR)
30.27%
What the Analysts think about Neogen
Analyst ratings (Buy, Hold, Sell) for Neogen stock.
Neogen Financial Performance
Revenues and expenses
Neogen Earnings Performance
Company profitability
Neogen News
AllArticlesVideos
Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs
Benzinga1 month ago
Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings
Benzinga1 month ago
Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neogen stock?
Neogen (NEOG) has a market cap of $1.4B as of November 16, 2025.
What is the P/E ratio for Neogen stock?
The price to earnings (P/E) ratio for Neogen (NEOG) stock is 0 as of November 16, 2025.
Does Neogen stock pay dividends?
No, Neogen (NEOG) stock does not pay dividends to its shareholders as of November 16, 2025.
When is the next Neogen dividend payment date?
Neogen (NEOG) stock does not pay dividends to its shareholders.
What is the beta indicator for Neogen?
Neogen (NEOG) has a beta rating of 1.9. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.